STK11 and non-small cell lung carcinoma: In patients with advanced LKB1-inactive NSCLC receiving platinum-pemetrexed chemotherapy, although metformin had been administered first, it could not improve prognosis in a phase II clinical trial, due to limited sample numbers [15].